Tomohisa Sakai

481 citations
42 papers · 288 indexed · h-index 10
Topics
Sarcoma Diagnosis and Treatment (19 papers)Soft tissue tumor case studies (14 papers)Neurofibromatosis and Schwannoma Cases (9 papers)
Partner nations
JapanUnited States

In The Last Decade

Tomohisa Sakai

37 papers receiving 282 citations

Peers

Tomohisa Sakai
Comparison fields: 5 of 64
  • Rheumatology 129
  • Pulmonary and Respiratory Medicine 93
  • Neurology 56
  • Pathology and Forensic Medicine 45
  • Surgery 37
Replace Liliana Voinea with:
Liliana Voinea Romania
Tominaga Shimizu Japan
Facundo Las Heras Chile
Caterina Marinelli Italy
Basel Al Kadah Germany
Itaru Tojyo Japan
Koung Hoon Kook South Korea
Hengxing Cai China
John Campana United States
Kundan L. Gupta United States
Tomohisa Sakai relative to Liliana Voinea Romania Liliana Voinea's profile →
Citations per field
00.5×3.3×
Liliana Voinea · 1×
Citations per year

Countries citing papers authored by Tomohisa Sakai

Since Specialization
Citations

This map shows the geographic impact of Tomohisa Sakai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomohisa Sakai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomohisa Sakai more than expected).

Fields of papers citing papers by Tomohisa Sakai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomohisa Sakai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomohisa Sakai. The network helps show where Tomohisa Sakai may publish in the future.

Co-authorship network of co-authors of Tomohisa Sakai

This figure shows the co-authorship network connecting the top 25 collaborators of Tomohisa Sakai. A scholar is included among the top collaborators of Tomohisa Sakai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomohisa Sakai. Tomohisa Sakai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 0
5 8
6 3
7 1
8 3
9 2
10 7
11 1
12 0
13 3
14 2
15 6
16 3
17 9
18 21
19 28
20 8

About Tomohisa Sakai

Tomohisa Sakai is a scholar working on Rheumatology, Oral Surgery and Neurology, having authored 42 papers that have together received 288 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (19 papers), Soft tissue tumor case studies (14 papers) and Neurofibromatosis and Schwannoma Cases (9 papers). The work is most often cited by research in Rheumatology (129 citations), Neurology (56 citations) and Oral Surgery (25 citations). Tomohisa Sakai has collaborated with scholars based in Japan and United States. Frequent co-authors include Yoshihiro Nishida, K. Ikuta, Hiroshi Koike, Shunsuke Hamada, Naoki Ishiguro, Hiroshi Urakawa, Shiro Imagama, Yoshie Shimoyama, Akihiro Sasoh and Fang Han. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026